CS: Rising Profit Margins And Multiples Will Drive Global Expansion

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

07 Nov 24

Updated

17 Dec 25

Views

181

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

22.2%

7D

0.9%

Loading

1Y

22.2%

7D

0.9%

You can edit this narrative until Dec 18 10:05 AM. Then, changes will post as Updates.

Author's Valuation

€45.078.8% undervalued

AnalystConsensusTarget Fair Value

Shared on 17 Dec 25

Fair value Increased 0.065%

CS: Lower Discount Rate Will Support Stronger Forward Earnings Appeal

Analysts have nudged their price target on AXA slightly higher to approximately €45.07 from about €45.04, citing a marginally lower discount rate and modest improvements in projected profit margins that together support a slightly richer valuation multiple. Valuation Changes Fair Value has risen slightly from approximately €45.04 to about €45.07, reflecting a marginal uplift in the intrinsic valuation estimate.

Shared on 03 Dec 25

CS: Modestly Higher Future Multiple Will Support Attractive Upside Potential

Analysts have modestly raised their price target on AXA to €45.04, citing a slightly higher assumed future price to earnings multiple, which more than offsets marginal adjustments to the discount rate and profit margin forecasts. Valuation Changes Fair Value Estimate unchanged at approximately €45.04 per share, indicating no revision to the intrinsic value assessment.

Shared on 19 Nov 25

Fair value Increased 0.20%

CS: Strong Profit Margins And Stable P/E Will Drive Future Gains

Analysts have slightly raised their price target for AXA, increasing it from €44.96 to €45.04. This change is based on modest adjustments to projected revenue growth, profit margins, and discount rates.

Shared on 02 Nov 25

Fair value Increased 0.85%

Analysts have slightly raised their price target for AXA from €44.58 to €44.96, citing incremental improvements in profit margin and expected future earnings multiples as key factors supporting the revision. Valuation Changes Fair Value has increased slightly from €44.58 to €44.96.

Shared on 01 May 25

Fair value Increased 4.37%

Shared on 23 Apr 25

Fair value Increased 0.26%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget has decreased revenue growth from 10.8% to 8.4%.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 1.77%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

Fair value Decreased 7.92%

AnalystConsensusTarget has decreased revenue growth from 14.7% to 10.6% and increased discount rate from 5.8% to 6.8%.

Shared on 19 Mar 25

Fair value Increased 0.066%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Increased 3.16%

AnalystConsensusTarget has increased revenue growth from 8.5% to 14.7%, decreased future PE multiple from 13.0x to 11.5x, decreased discount rate from 6.6% to 5.8% and decreased shares outstanding growth rate from -0.0% to -0.0%.

AnalystConsensusTarget Fair Value

€45.07

8.8% undervalued

Future estimation in

Growth p.a.

Growth p.a.

%

Decrease

Increase

Current revenue growth rate

7.29%

Insurance revenue growth rate

0.27%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

6.78%

Calculation

€8.91b

Earnings '28

x

12.40x

PE Ratio '28

=

€110.45b

Market Cap '28

€110.45b

Market Cap '28

/

2.01b

No. shares '28

=

€54.89

Share Price '28

€54.89 Share Price '28

Discounted to 2025 @ 6.79% p.a.

=

€45.07

Fair Value '25